Foley Hoag LLP
Compositions, methods and kits for diagnosis of lung cancer
The present invention provides methods for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung condition. The present invention also provides compositions comprising these biomarker proteins and methods of using these biomarker proteins or panels thereof to diagnose, classify, and monitor various lung conditions. The methods and compositions provided herein may be used to diagnose or classify a subject as having lung cancer or a non-cancerous condition, and to distinguish between different types of cancer (e.g., malignant versus benign, SCLC versus NSCLC).
Biodesix, Inc.
G G G G G G G G
G01N G16B G01N G01N G01N G01N G01N G01N
inventional additional additional additional inventional additional additional additional
Xiao-Jun Paul Edward Clive Kenneth Charles
Li Kearney Hayward Fang